Dr Reddy’s Sputnik V vaccine application to be taken up today; here's what it means for the company

A Subject Expert Committee (SEC) is all set to meet today to once again take cognizance of Dr Reddy’s application for the Sputnik V COVID-19 vaccine. In the last meeting, the SEC had reservations on the logistics and hence did not give the Emergency Use Authorization (EUA) to the vaccine. SEC had also sought more data on trials, efficacy, etc.

Also, watch CNBC-TV18’s Ekta Batra outline the details of the vaccine and its impact on Dr Reddy’s if it receives EUA.